Adenosine
Generic name
Adenosine
Trade name
Adenocor®
Classification
Anti-arrhythmic
Indication
Paroxysmal supraventricular tachycardias, cardiac dysrhythmias.
Dosage form
6 mg/2 ml/vial
Dose
Initial dose:
3 mg as a rapid intravenous bolus.
Second dose: If the first dose does not result in elimination of the supraventricular tachycardia within 1 or 2 minutes, then 6 mg should be given also as a rapid intravenous bolus.
Third dose: If the second dose does not result in elimination of the supraventricular tachycardia within 1 or 2 minutes, then 12 mg should be given also as a rapid intravenous bolus.
A maximum total dose of 21 mg or 300 mcg/kg is recommended.
Administration
IV bolus
Intravenous Concentration
Bolus undiluted
Intravenous Rate
Rapid injection over 2 seconds
Storage
เก็บอุณหภูมิต่ำกว่า 25 C, ป้องกันแสง, ห้ามเก็บในตู้เย็น
Reconstitution
Not required.
Stability
Discard any unused solution.
Compatible fluid
NSS
Incompatible fluid
Incompatible drug
Adverse effect
Flushing, dyspnoea, chest discomfort or constriction, nausea, sweating, palpitations, hyperventilation, apprehension, lightheadedness, blurred vision, burning sensation, bradycardia, chest pains,
Precaution
Contraindication
